Combined [18F]-Fluoroethylcholine PET/CT and 99mTc–Macroaggregated Albumin SPECT/CT Predict Survival in Patients With Intermediate-Stage Hepatocellular Carcinoma
Conclusions
Hepatocellular carcinoma with high vascularization in metabolic active areas as assessed by combined FEC PET/CT and Tc-MAA SPECT/CT represents an unfavorable subgroup with reduced overall survival after radioembolization.
Source: Clinical Nuclear Medicine - Category: Nuclear Medicine Tags: Original Articles Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | CT Scan | Hepatocellular Carcinoma | Laboratory Medicine | Liver | Liver Cancer | Nuclear Medicine | PET Scan | SPECT | Statistics | Study | Urology & Nephrology